NCT04029987

Brief Summary

To compare between the intra muscular quadratous lamborum and the Trans muscular quadratous lamborum in pediatric population under going abdominal surgeries regards to first request of rescue analgesia, degree of pain relief, effect on hemo dynamic stability and incidence of complications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 25, 2018

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 2, 2018

Completed
8 months until next milestone

First Posted

Study publicly available on registry

July 23, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2019

Completed
Last Updated

January 22, 2020

Status Verified

January 1, 2020

Enrollment Period

11 months

First QC Date

December 2, 2018

Last Update Submit

January 19, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Time of the first postoperative analgesic request

    (duration of the block, time spent post-operative before rescue opioid is needed at pain score of 6 or higher, up to 12 hours post operative.

    starting 15 minutes post extubation, then at time intervals of 30 minutes , 60 minutes, 6 hours and 12 hours

Secondary Outcomes (6)

  • total opioid consumption over the first 12 hours.

    through out the first 12 hours post operative.

  • Pain score up to 12 hours after surgery.

    through out the first 12 hours post operative.

  • Block failure

    through out the first hour post operative.

  • Ease of performance of each technique

    through out the block performance time

  • Block performance time

    starting from probe contact with skin till 30 minutes.

  • +1 more secondary outcomes

Other Outcomes (6)

  • patient's heart rate

    starting from 5 minutes after intubation till 30 minutes after extubation

  • patient's systolic blood pressure

    starting from 5 minutes after intubation till 30 minutes after extubation

  • patient's diastolic blood pressure

    starting from 5 minutes after intubation till 30 minutes after extubation

  • +3 more other outcomes

Study Arms (3)

Trans Muscular Quadratus Lumborum fascial plane Block

ACTIVE COMPARATOR

In group (Trans Muscular Quadratus Lumborum Block),will undergo ultrasound guided trans-muscular quadratus lamborum block as follows: A 22 G echogenic needle will be inserted in plane from the posterior (medial) end of the probe and directed for the fascial plane between the Quadratus Lumborum and the Psoas Major muscles through the Quadratus Lumborum muscle. Once the needle is confirmed in correct location, 1 mL of saline will be injected after negative aspiration. Then 0.5 mL/Kg per side of bupivacaine 0.25% will be injected. The spread of the injectate should be observed to distribute within this plane. This technique will be repeated to the other side.

Procedure: Bilateral Ultrasound-Guided Transmuscular Quadratus Lumborum Block.

Intra Muscular Quadratus Lumborum fascial plane Block

ACTIVE COMPARATOR

In group Intra Muscular Quadratus Lumborum Block ,will undergo ultrasound guided intra-muscular quadratus lamborum (QL) block as follows: A 22 G echogenic needle will be inserted in plane from ventral (lateral) edge of the probe and advanced until penetration of QL muscle fascia is observed. Once the needle is confirmed in correct location, 1 mL of saline will be injected after negative aspiration. Then 0.5 mL/Kg per side of bupivacaine 0.25% will be injected. The spread of the injectate should be observed to distribute within this plane. This technique will be repeated to the other side.

Procedure: Bilateral Ultrasound-Guided intra smuscular Quadratus Lumborum Block.

group c → control

PLACEBO COMPARATOR

group c → control ,will receive conventional analgesia in the form of paracetamol with 15 mg\\ k.g every 6 hours, and naluphin 0.1 mg \\kg on demands

Procedure: Control

Interventions

A 22 G echogenic needle will be inserted in plane from the posterior (medial) end of the probe and directed for the fascial plane between the Quadratus Lumborum and the Psoa Major muscles through the Quadratus Lumborum muscle. Once the needle is confirmed in correct location, 1 mL of saline will be injected after negative aspiration. Then 0.5 mL/Kg of bupivacaine 0.25% will be injected. The spread of the injectate should be observed to distribute within this plane. This technique will be repeated to the other side.

Trans Muscular Quadratus Lumborum fascial plane Block

A 22 G echogenic needle will be inserted in plane from ventral (lateral) edge of the probe and advanced until penetration of QL muscle fascia is observed. Once the needle is confirmed in correct location, 1 mL of saline will be injected after negative aspiration. Then 0.5 mL/Kg of bupivacaine 0.25% will be injected. The spread of the injectate should be observed to distribute within this plane. This technique will be repeated to the other side.

Intra Muscular Quadratus Lumborum fascial plane Block
ControlPROCEDURE

Conventional analgesia

group c → control

Eligibility Criteria

Age5 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Children age starting from 5 to 12 years.
  • Genders eligible for study: both sexes.
  • American Society Of Anesthesia (ASA) I-III.
  • Scheduled to undergo laparoscopy.

You may not qualify if:

  • Refusal of regional block or patients requiring emergency procedures.
  • Known Local Anesthetics drug sensitivity
  • Bleeding disorders with International Normalised Ratio (INR) \> 1.5 and/or platelets \< 100 000.
  • Skin lesions or wounds at site of proposed needle insertion.
  • Evidence of peritonitis or septicemia.
  • Hepatic disease or enlargement.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Abu ElReesh hospital, Cairo university Hospital,Kasr Alini

Cairo, 11562, Egypt

Location

MeSH Terms

Conditions

Acute Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Patients, parents and data analysts will be blinded to group assignments.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: age:5-12, American Society of Anesthesia I-III, abdominal laparoscopies, randomly allocated into one of the study groups, randomization sequence will be concealed in sealed envelopes with alphabetic codes. The identifiers will be attached to the opened envelopes and secured by dedicated person independent of randomization proceedings. Patients, parents and data analysts will be blinded to group assignments. The groups: * group A → Trans muscular quadrous lamborum block (n=22) * group B → Intra muscular quadrous lamborum block (n=22) * group c → control (n=22) will receive conventional analgesia. Sample size Starting number of 22 patients for each group, Recalculation of the sample size will be carried out after studying 10 patients per group. The alpha error is set at 0.05 and the study power is 0.95.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 2, 2018

First Posted

July 23, 2019

Study Start

October 25, 2018

Primary Completion

October 1, 2019

Study Completion

October 1, 2019

Last Updated

January 22, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share

Locations